ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
BioVie Inc

BioVie Inc (BIVI)

0.4542
-0.0058
(-1.26%)
Closed May 27 4:00PM
0.47
0.0158
(3.48%)
After Hours: 7:49PM

Calls

StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
2.500.050.050.050.050.000.00 %062-
5.000.000.000.000.000.000.00 %00-

Professional-Grade Tools, for Individual Investors.

Puts

StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
2.500.000.000.000.000.000.00 %00-
5.004.105.000.004.550.000.00 %00-

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LUCYInnovative Eyewear Inc
$ 0.983
(428.49%)
944.4M
AKANAkanda Corporation
$ 4.07
(70.29%)
39.11M
TKLFYoshitsu Company Ltd
$ 0.3496
(53.33%)
84.5M
ONMDOneMedNet Corporation
$ 2.251
(53.13%)
136.04M
MRUSMerus NV
$ 59.92
(35.97%)
6.91M
VSTMVerastem Inc
$ 4.0901
(-66.42%)
19.68M
TOIIWOncology Institute Inc
$ 0.0443
(-55.61%)
280.55k
SNSESensei Biotherapeutics Inc
$ 0.7912
(-45.43%)
1.41M
GNLXGenelux Corporation
$ 2.61
(-43.26%)
3.32M
AUVIApplied UV Inc
$ 0.32
(-33.33%)
5.18M
LUCYInnovative Eyewear Inc
$ 0.983
(428.49%)
944.4M
GWAVGreenwave Technology Solutions Inc
$ 0.0843
(-4.85%)
428.98M
NCPLNetcapital Inc
$ 0.20
(14.42%)
191.35M
HLTHCue Health Inc
$ 0.0931
(-1.27%)
160.21M
ONMDOneMedNet Corporation
$ 2.251
(53.13%)
136.04M

BIVI Discussion

View Posts
urge2surge urge2surge 3 weeks ago
Well apparently this is another small cap bio dead dog. Rip...Sheesh..
๐Ÿ‘๏ธ0
urge2surge urge2surge 1 month ago
Getting perky for turn upside!
๐Ÿ‘๏ธ0
microchips microchips 1 month ago
BIVI is waking up... Possible turn around on a swing trade or investment.
๐Ÿ‘๏ธ0
Monksdream Monksdream 2 months ago
BIVI new 52 lo
๐Ÿ‘๏ธ0
bikaver bikaver 2 months ago
BIVI.....Picked up .5250's on Thursday.....Due for a bounce.
๐Ÿ‘๏ธ0
Monksdream Monksdream 3 months ago
BIVI new 52 week lo
๐Ÿ‘๏ธ0
Monksdream Monksdream 3 months ago
BIVI new 52 week low
๐Ÿ‘๏ธ0
Monksdream Monksdream 3 months ago
BIVI new 52=week low
๐Ÿ‘๏ธ0
FooBarAndGrill FooBarAndGrill 3 months ago
It ran alright ... ran right down to that $1 offering price.
๐Ÿ‘๏ธ0
bigfart bigfart 3 months ago
I wonder if this will run on Monday
๐Ÿ‘๏ธ0
microchips microchips 3 months ago
Impressive Trial Updates
👍️ 1
Stingray Stingray 3 months ago
Brave soul...I wouldn't sell till maybe after the conference March 8-9...maybe the 7th...this stock is wound up pretty tight...seems to have lots more upside than down side...
๐Ÿ‘๏ธ0
TimeFades TimeFades 3 months ago
Short
๐Ÿ‘๏ธ0
midastouch017 midastouch017 3 months ago
BioVieโ€™s NE3107 Demonstrates Potential Improvements in Motor and Non-motor Symptoms for Parkinsonโ€™s Disease Patients and May Be Realigning Physiological Processes for Alzheimerโ€™s Patients in Data to be Presented at the International Conference on Alzheimerโ€™s and Parkinsonโ€™s Diseases 2024

https://finance.yahoo.com/news/biovie-ne3107-demonstrates-potential-improvements-130000143.html
๐Ÿ‘๏ธ0
DJPele DJPele 3 months ago
BioVie Shares Double After Positive Data for Parkinson's Disease Treatment


BioVie shares doubled to $2.89 in premarket trading Friday after the company said its Phase 2A study of NE3107 suggested improvements in non-motor symptoms in patients with Parkinson's disease.

The company said these findings complement previously reported improvement in motor symptoms in patients treated with NE3107 and demonstrate potential intrinsic, levodopa-enhancing activity of NE3107 that is consistent with data from animal models.

NE3107-treated patients experienced a significant improvement for the sleep/fatigue domain of the Non-Motor Symptom Scale in Parkinson's disease, whereas placebo patients experienced a worsening.

Sleep/fatigue domain improvements correlated with motor score improvements. More patients on NE3107 had improvements in the NMSS sleep/fatigue domain, while more patients on placebo worsened.


https://www.google.com/amp/s/www.marketwatch.com/amp/story/biovie-shares-double-after-positive-data-for-parkinson-s-disease-treatment-6fca8fee
๐Ÿ‘๏ธ0
Awl416 Awl416 3 months ago
What leaked?
๐Ÿ‘๏ธ0
Monksdream Monksdream 4 months ago
BIVI new 52 week low
๐Ÿ‘๏ธ0
Hoskuld Hoskuld 6 months ago
If it is true they can continue the study and add more patients at compliant clinical sites then that is one good reason to buy - after all they have a strong signal already. And of course Ascites...that is bigger than most seem to think.
๐Ÿ‘๏ธ0
Stingray Stingray 6 months ago
BIVI seems like a good buy after that sharp drop! I've watched this stock do the same before. After news a huge drop, then a big run! Is there a good reason not to buy BIVI below $2?

https://finance.yahoo.com/news/biovie-bivi-falls-61-despite-152000388.html

BioVie (BIVI) Falls 61% Despite Upbeat Alzheimer's Study Data
๐Ÿ‘๏ธ0
FooBarAndGrill FooBarAndGrill 6 months ago
re. 'single entity?'
Only if the individual sites were all under a single umbrella, which I don't know.
Longer answer: We're talking about this clinical trial.
Now if you look at that trial, you will only find one study location mentioned: The Ohio State University
However, if you look at the history of changes, you'll see the list of locations was deleted by the last change done on November 20, 2023
That's something like, what, 32 sites gone.
๐Ÿ‘๏ธ0
Hoskuld Hoskuld 6 months ago
Do you think all those clinics were run by a single entity?
๐Ÿ‘๏ธ0
FooBarAndGrill FooBarAndGrill 6 months ago
Yes, I agree it's not clear. Sorry. The CROs and demographic group are unnamed. I'm guessing the lawyer is filtering those details. Call it Florida/Covid crazy.
๐Ÿ‘๏ธ0
Hoskuld Hoskuld 6 months ago
FWIW, I don't read a clear explanation just a statement that there were issues. How did 15 clinics fail to follow protocol?
๐Ÿ‘๏ธ0
FooBarAndGrill FooBarAndGrill 6 months ago
Today's PR clearly explains. See the section 'Data Review and Audit'.
November 29, 2023 PR
๐Ÿ‘๏ธ0
Hoskuld Hoskuld 6 months ago
How were 80% of patients treated using the wrong protocol or at least no using the approved protocol? How does this happen?
๐Ÿ‘๏ธ0
hedge_fun hedge_fun 6 months ago
It happens, but also provided a nice trade this am.......
๐Ÿ‘๏ธ0
stock1ace1 stock1ace1 6 months ago
Bulls got slaughtered ouch
๐Ÿ‘๏ธ0
hedge_fun hedge_fun 6 months ago
@#&%!*........

Didn't wanna cuss.

Freakin' data.
๐Ÿ‘๏ธ0
FooBarAndGrill FooBarAndGrill 6 months ago
Biovie Webinar:
Date & Time: Dec 7, 2023 03:15 PM Central
Zoom Registration
๐Ÿ‘๏ธ0
runncoach runncoach 6 months ago
Peeved, I've never been real big on this one but had hopes without following closely. This latest revelation really puts their credibility on the line
๐Ÿ‘๏ธ0
peeved peeved 6 months ago
Any thoughts on the blinded data runncoach?

It really looks good imo
๐Ÿ‘๏ธ0
runncoach runncoach 7 months ago
Wow. I've never been in this one but that really is potentially about as bad as it gets I would think
๐Ÿ‘๏ธ0
FooBarAndGrill FooBarAndGrill 7 months ago
This guy with this posting is likely the nature of these 'good clinical practices' irregularities. And before he deletes the post, I've captured the screen.
Actual Twitter Post (while it lasts)
And my copy here.
๐Ÿ‘๏ธ0
FooBarAndGrill FooBarAndGrill 7 months ago
$BIVI 10-Q issued today.
A section on 'good clinical practices' (GCP) contains the reason for the drop.
Official 10-Q
๐Ÿ‘๏ธ0
hedge_fun hedge_fun 7 months ago
#bloodbath
๐Ÿ‘๏ธ0
hedge_fun hedge_fun 7 months ago
Good update from the CEO. Long for the next few years, but I think they'll be many trading opportunities here with quite the volatility in that time frame.

The unblinded results might give BIVI a pop, but I would expect a drop too. It's the nature of these plays.

We'll see.
๐Ÿ‘๏ธ0
FooBarAndGrill FooBarAndGrill 7 months ago
Aha! Official: just found how to embed yt videos
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=39097864

and it works
๐Ÿ‘๏ธ0
FooBarAndGrill FooBarAndGrill 7 months ago
Sorry. IHUB tries (and fails) to preview naked YT links.
Let's try this.
๐Ÿ‘๏ธ0
hedge_fun hedge_fun 7 months ago
Can you edit? The video isn't playing.....
๐Ÿ‘๏ธ0
FooBarAndGrill FooBarAndGrill 7 months ago
$BIVI promotional update.
๐Ÿ‘๏ธ0
FooBarAndGrill FooBarAndGrill 7 months ago
Sandbagging? Oh yeah. Expensive lawyers give this advice. lol..
๐Ÿ‘๏ธ0
hedge_fun hedge_fun 7 months ago
I can't remember the Dr.s name that was on the call that got most of the questions during the Q&A, but he said he had low expectations.

Do you think he was sandbagging?
๐Ÿ‘๏ธ0
FooBarAndGrill FooBarAndGrill 7 months ago
I'm just playing catch-up here so this is good to me.
They certainly seem excited to be presenting the blinded data.
Like "We don't know" but, really "We know".
๐Ÿ‘๏ธ0
hedge_fun hedge_fun 7 months ago
I listened live this am. They didn't really tell us anything we didn't know. Maybe the unblinded data will surprise.

Price is holding up pretty well considering, but this has always been a long-term hold for me.

GL
๐Ÿ‘๏ธ0
FooBarAndGrill FooBarAndGrill 7 months ago
Nov 1 Conference call replay after registration:
https://viavid.webcasts.com/starthere.jsp?ei=1641876&tp_key=48e56ba402
๐Ÿ‘๏ธ0
FooBarAndGrill FooBarAndGrill 7 months ago
Conference call. 1 p3 done, still blinded. If, after un-blinding, results are as expected, AA may be a path to pursue with FDA. Otherwise a 2nd P3 is on the table.
https://bioviepharma.com/wp-content/uploads/2023/11/BioVie-Conference-Call-2023-11-01.pdf
๐Ÿ‘๏ธ0
hedge_fun hedge_fun 7 months ago
Posted yesterday about the Conference callโ€ฆ..

The Carson City, Nev.-based clinical-stage pharmaceutical company said Monday morning it would host a conference call Nov. 1 to discuss the blinded data on its Phase 3 clinical trial of NE3107 in the treatment of mild to moderate Alzheimer's.

Registration details are as follows:
Date November 1, 2023
Time 8:00 AM Eastern Time
Conference Call Details 1-877-407-3982 (U.S. Investors Dial-in)

1-201-493-6780 (International Investors Dial-in)

13742478 (Conference ID Code)
👍️ 1
FooBarAndGrill FooBarAndGrill 7 months ago
What data are we expecting tomorrow?
The CTAD presentation seemed to be packed with data:
https://www.sec.gov/Archives/edgar/data/1580149/000152013823000457/bivi-20231025_8kex99z1.htm
๐Ÿ‘๏ธ0
hedge_fun hedge_fun 7 months ago
Hopefully no sell off on the data tomorrowโ€ฆ..
๐Ÿ‘๏ธ0
hedge_fun hedge_fun 7 months ago
Nice move up today. Hopefully a new trendโ€ฆโ€ฆ
๐Ÿ‘๏ธ0

Your Recent History

Delayed Upgrade Clock